{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:55:45Z","timestamp":1790823345848,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"DOI":"10.1038\/s41401-026-01942-2","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:21:36Z","timestamp":1790814096000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gambogenic acid globally regulates translational processes in Nrf2-mutant esophageal squamous cell carcinoma by promoting Nrf2\/MafG protein multimerization"],"prefix":"10.1038","author":[{"given":"Yu-ying","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-feng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-qi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-fei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-peng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Xuan Truong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-qiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuai-le","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-ge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"1942_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"1942_CR2","first-page":"21","volume":"3","author":"R Chen","year":"2023","unstructured":"Chen R, Zheng R, Zhang S, Wang S, Sun K, Zeng H, et al. Patterns and trends in esophageal cancer incidence and mortality in China: an analysis based on cancer registry data. J Natl Cancer Cent. 2023;3:21\u20137.","journal-title":"J Natl Cancer Cent"},{"key":"1942_CR3","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/S0140-6736(24)02226-8","volume":"404","author":"H Yang","year":"2024","unstructured":"Yang H, Wang F, Hallemeier CL, Lerut T, Fu J. Oesophageal cancer. Lancet. 2024;404:1991\u20132005.","journal-title":"Lancet"},{"key":"1942_CR4","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41422-020-0333-6","volume":"30","author":"Y Cui","year":"2020","unstructured":"Cui Y, Chen H, Xi R, Cui H, Zhao Y, Xu E, et al. Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma. Cell Res. 2020;30:902\u201313.","journal-title":"Cell Res"},{"key":"1942_CR5","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1053\/j.gastro.2016.01.035","volume":"150","author":"G Sawada","year":"2016","unstructured":"Sawada G, Niida A, Uchi R, Hirata H, Shimamura T, Suzuki Y, et al. Genomic landscape of esophageal squamous cell carcinoma in a Japanese population. Gastroenterology. 2016;150:1171\u201382.","journal-title":"Gastroenterology"},{"key":"1942_CR6","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1158\/2159-8290.CD-21-0922","volume":"12","author":"R Pillai","year":"2022","unstructured":"Pillai R, Hayashi M, Zavitsanou AM, Papagiannakopoulos T. NRF2: KEAPing tumors protected. Cancer Discov. 2022;12:625\u201343.","journal-title":"Cancer Discov"},{"key":"1942_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.semcancer.2021.05.016","volume":"76","author":"CJ Schmidlin","year":"2021","unstructured":"Schmidlin CJ, Shakya A, Dodson M, Chapman E, Zhang DD. The intricacies of NRF2 regulation in cancer. Semin Cancer Biol. 2021;76:110\u20139.","journal-title":"Semin Cancer Biol"},{"key":"1942_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.semcancer.2021.06.003","volume":"76","author":"J Sivinski","year":"2021","unstructured":"Sivinski J, Zhang DD, Chapman E. Targeting NRF2 to treat cancer. Semin Cancer Biol. 2021;76:61\u201373.","journal-title":"Semin Cancer Biol"},{"key":"1942_CR9","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1158\/2159-8290.CD-20-0282","volume":"10","author":"MS Binkley","year":"2020","unstructured":"Binkley MS, Jeon YJ, Nesselbush M, Moding EJ, Nabet BY, Almanza D, et al. KEAP1\/NFE2L2 mutations predict lung cancer radiation resistance that can be targeted by glutaminase inhibition. Cancer Discov. 2020;10:1826\u201341.","journal-title":"Cancer Discov"},{"key":"1942_CR10","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1158\/1078-0432.CCR-08-2822","volume":"15","author":"S Homma","year":"2009","unstructured":"Homma S, Ishii Y, Morishima Y, Yamadori T, Matsuno Y, Haraguchi N, et al. Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer. Clin Cancer Res. 2009;15:3423\u201332.","journal-title":"Clin Cancer Res"},{"key":"1942_CR11","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41586-024-07943-7","volume":"635","author":"F Skoulidis","year":"2024","unstructured":"Skoulidis F, Araujo HA, Do MT, Qian Y, Sun X, Galan-Cobo A, et al. CTLA4 blockade abrogates KEAP1\/STK11-related resistance to PD-(L)1 inhibitors. Nature. 2024;635:462\u201371.","journal-title":"Nature"},{"key":"1942_CR12","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.cell.2016.06.056","volume":"166","author":"IIC Chio","year":"2016","unstructured":"Chio IIC, Jafarnejad SM, Ponz-Sarvise M, Park Y, Rivera K, Palm W, et al. NRF2 promotes tumor maintenance by modulating mRNA translation in pancreatic cancer. Cell. 2016;166:963\u201376.","journal-title":"Cell"},{"key":"1942_CR13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"AG Atanasov","year":"2021","unstructured":"Atanasov AG, Zotchev SB, Dirsch VM, Supuran CT. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021;20:200\u201316.","journal-title":"Nat Rev Drug Discov"},{"key":"1942_CR14","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/jssc.200600294","volume":"30","author":"JZ Song","year":"2007","unstructured":"Song JZ, Yip YK, Han QB, Qiao CF, Xu HX. Rapid determination of polyprenylated xanthones in gamboge resin of Garcinia hanburyi by HPLC. J Sep Sci. 2007;30:304\u20139.","journal-title":"J Sep Sci"},{"key":"1942_CR15","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.2147\/DDDT.S426685","volume":"17","author":"R He","year":"2023","unstructured":"He R, Jia B, Peng D, Chen W. Caged polyprenylated xanthones in Garcinia hanburyi and the biological activities of them. Drug Des Devel Ther. 2023;17:3625\u201360.","journal-title":"Drug Des Devel Ther"},{"key":"1942_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12906-015-0710-8","volume":"15","author":"Y He","year":"2015","unstructured":"He Y, Ding J, Lin Y, Li J, Shi Y, Wang J, et al. Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin. BMC Complement Altern Med. 2015;15:181.","journal-title":"BMC Complement Altern Med"},{"key":"1942_CR17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1055\/a-2258-6663","volume":"90","author":"L Mi","year":"2024","unstructured":"Mi L, Xing Z, Zhang Y, He T, Su A, Wei T, et al. Unveiling gambogenic acid as a promising antitumor compound: a review. Planta Med. 2024;90:353\u201367.","journal-title":"Planta Med"},{"key":"1942_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03596-w","volume":"12","author":"X Luo","year":"2021","unstructured":"Luo X, Zheng E, Wei L, Zeng H, Qin H, Zhang X, et al. The fatty acid receptor CD36 promotes HCC progression through activating Src\/PI3K\/AKT axis-dependent aerobic glycolysis. Cell Death Dis. 2021;12:328.","journal-title":"Cell Death Dis"},{"key":"1942_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.drudis.2012.10.003","volume":"18","author":"S Breslin","year":"2013","unstructured":"Breslin S, O\u2019Driscoll L. Three-dimensional cell culture: the missing link in drug discovery. Drug Discov Today. 2013;18:240\u20139.","journal-title":"Drug Discov Today"},{"key":"1942_CR20","first-page":"6999","volume":"14","author":"D Lv","year":"2017","unstructured":"Lv D, Hu Z, Lu L, Lu H, Xu X. Three-dimensional cell culture: a powerful tool in tumor research and drug discovery. Oncol Lett. 2017;14:6999\u20137010.","journal-title":"Oncol Lett"},{"key":"1942_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-01853-8","volume":"21","author":"SJ Han","year":"2021","unstructured":"Han SJ, Kwon S, Kim KS. Challenges of applying multicellular tumor spheroids in preclinical phase. Cancer Cell Int. 2021;21:152.","journal-title":"Cancer Cell Int"},{"key":"1942_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111265","volume":"136","author":"LQ Yang","year":"2021","unstructured":"Yang LQ, Yu SP, Yang YT, Zhao YS, Wang FY, Chen Y, et al. Muscone derivative ZM-32 inhibits breast tumor angiogenesis by suppressing HuR-mediated VEGF and MMP9 expression. Biomed Pharmacother. 2021;136:111265.","journal-title":"Biomed Pharmacother"},{"key":"1942_CR23","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1021\/acs.molpharmaceut.1c00030","volume":"18","author":"B Wang","year":"2021","unstructured":"Wang B, Yuan T, Zha L, Liu Y, Chen W, Zhang C, et al. Oral delivery of gambogenic acid by functional polydopamine nanoparticles for targeted tumor therapy. Mol Pharmacol. 2021;18:1470\u20139.","journal-title":"Mol Pharm"},{"key":"1942_CR24","first-page":"1700","volume":"41","author":"T Huang","year":"2019","unstructured":"Huang T, Zhang H, Wang X, Xu L, Jia J, Zhu X. Gambogenic acid inhibits the proliferation of small\u2011cell lung cancer cells by arresting the cell cycle and inducing apoptosis. Oncol Rep. 2019;41:1700\u20136.","journal-title":"Oncol Rep"},{"key":"1942_CR25","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3390\/ph18030374","volume":"18","author":"M Wang","year":"2025","unstructured":"Wang M, Liu J, Yu W, Shao J, Bao Y, Jin M, et al. Gambogenic acid suppresses malignant progression of non-small cell lung cancer via GCH1-mediated ferroptosis. Pharmaceuticals. 2025;18:374.","journal-title":"Pharmaceuticals"},{"key":"1942_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnves.2024.100003","volume":"1","author":"Q-Y Zhang","year":"2025","unstructured":"Zhang QY, Huang RP, Wu F, Ye HE, Yan CY, Gong HB, et al. Antioxidant dipeptide, cyclo (Phe-Phe), protects against bone dysplasia by suppression of phospholipid peroxidation. Cell Investig. 2025;1:100003.","journal-title":"Cell Investig"},{"key":"1942_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13045-016-0386-7","volume":"10","author":"G Liu","year":"2017","unstructured":"Liu G, Zhang J, Frey L, Gang X, Wu K, Liu Q, et al. Prostate-specific IL-6 transgene autonomously induce prostate neoplasm through amplifying inflammation in the prostate and peri-prostatic adipose tissue. J Hematol Oncol. 2017;10:14.","journal-title":"J Hematol Oncol"},{"key":"1942_CR28","doi-asserted-by":"publisher","first-page":"W739","DOI":"10.1093\/nar\/gkac382","volume":"50","author":"A Ianevski","year":"2022","unstructured":"Ianevski A, Giri AK, Aittokallio T. SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples. Nucleic Acids Res. 2022;50:W739\u2013w43.","journal-title":"Nucleic Acids Res"},{"key":"1942_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/cpsc.109","volume":"53","author":"TA Karakasheva","year":"2020","unstructured":"Karakasheva TA, Kijima T, Shimonosono M, Maekawa H, Sahu V, Gabre JT, et al. Generation and characterization of patient-derived head and neck, oral, and esophageal cancer organoids. Curr Protoc Stem Cell Biol. 2020;53:e109.","journal-title":"Curr Protoc Stem Cell Biol"},{"key":"1942_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103440","volume":"24","author":"B Zheng","year":"2021","unstructured":"Zheng B, Ko KP, Fang X, Wang X, Zhang J, Jun S, et al. A new murine esophageal organoid culture method and organoid-based model of esophageal squamous cell neoplasia. iScience. 2021;24:103440.","journal-title":"iScience"},{"key":"1942_CR31","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nmeth.1212","volume":"5","author":"M Gutscher","year":"2008","unstructured":"Gutscher M, Pauleau AL, Marty L, Brach T, Wabnitz GH, Samstag Y, et al. Real-time imaging of the intracellular glutathione redox potential. Nat Methods. 2008;5:553\u20139.","journal-title":"Nat Methods"},{"key":"1942_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01730-x","volume":"8","author":"J Deng","year":"2017","unstructured":"Deng J, Chen H, Zhou D, Zhang J, Chen Y, Liu Q, et al. Comparative genomic analysis of esophageal squamous cell carcinoma between Asian and Caucasian patient populations. Nat Commun. 2017;8:1533.","journal-title":"Nat Commun"},{"key":"1942_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302425","volume":"10","author":"J Song","year":"2023","unstructured":"Song J, Li H, Liu Y, Li X, Shi Q, Lei QY, et al. Aldolase A accelerates cancer progression by modulating mRNA translation and protein biosynthesis via noncanonical mechanisms. Adv Sci. 2023;10:e2302425.","journal-title":"Adv Sci"},{"key":"1942_CR34","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S. AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings. J Chem Inf Model. 2021;61:3891\u20138.","journal-title":"J Chem Inf Model"},{"key":"1942_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116458","volume":"227","author":"C Luo","year":"2024","unstructured":"Luo C, Chen G, Li R, Peng S, Zhang P, Wang F, et al. Juglone suppresses vasculogenic mimicry in glioma through inhibition of HuR-mediated VEGF-A expression. Biochem Pharmacol. 2024;227:116458.","journal-title":"Biochem Pharmacol"},{"key":"1942_CR36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12929-022-00873-4","volume":"29","author":"CH Hsieh","year":"2022","unstructured":"Hsieh CH, Kuan WH, Chang WL, Kuo IY, Liu H, Shieh DB, et al. Dysregulation of SOX17\/NRF2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma. J Biomed Sci. 2022;29:90.","journal-title":"J Biomed Sci"},{"key":"1942_CR37","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1593\/neo.11750","volume":"13","author":"T Shibata","year":"2011","unstructured":"Shibata T, Kokubu A, Saito S, Narisawa-Saito M, Sasaki H, Aoyagi K, et al. NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer. Neoplasia. 2011;13:864\u201373.","journal-title":"Neoplasia"},{"key":"1942_CR38","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/path.2653","volume":"220","author":"YR Kim","year":"2010","unstructured":"Kim YR, Oh JE, Kim MS, Kang MR, Park SW, Han JY, et al. Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin. J Pathol. 2010;220:446\u201351.","journal-title":"J Pathol"},{"key":"1942_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05696-5","volume":"22","author":"Y Wu","year":"2024","unstructured":"Wu Y, Ma Y, Li Q, Li J, Zhang D, Zhang Y, et al. Multi-omics analysis reveals phenylalanine enhance mitochondrial function and hypoxic endurance via LKB1\/AMPK activation. J Transl Med. 2024;22:920.","journal-title":"J Transl Med"},{"key":"1942_CR40","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1083\/jcb.201804161","volume":"217","author":"A Bansal","year":"2018","unstructured":"Bansal A, Simon MC. Glutathione metabolism in cancer progression and treatment resistance. J Cell Biol. 2018;217:2291\u20138.","journal-title":"J Cell Biol"},{"key":"1942_CR41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2317846121","volume":"121","author":"YS Kim","year":"2024","unstructured":"Kim YS, Kimball SR, Piskounova E, Begley TJ, Hempel N. Stress response regulation of mRNA translation: implications for antioxidant enzyme expression in cancer. Proc Natl Acad Sci USA. 2024;121:e2317846121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1942_CR42","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3390\/cancers13040639","volume":"13","author":"VR Sanghvi","year":"2021","unstructured":"Sanghvi VR, Mohan P, Singh K, Cao L, Berishaj M, Wolfe AL, et al. NRF2 activation confers resistance to eIF4A inhibitors in cancer therapy. Cancers (Basel). 2021;13:639.","journal-title":"Cancers (Basel)"},{"key":"1942_CR43","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1158\/0008-5472.CAN-14-2789","volume":"75","author":"J Pelletier","year":"2015","unstructured":"Pelletier J, Graff J, Ruggero D, Sonenberg N. Targeting the eIF4F translation initiation complex: a critical nexus for cancer development. Cancer Res. 2015;75:250\u201363.","journal-title":"Cancer Res"},{"key":"1942_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1158\/1078-0432.CCR-14-2362","volume":"23","author":"H Malka-Mahieu","year":"2017","unstructured":"Malka-Mahieu H, Newman M, D\u00e9saubry L, Robert C, Vagner S. Molecular pathways: the eIF4F translation initiation complex-new opportunities for cancer treatment. Clin Cancer Res. 2017;23:21\u20135.","journal-title":"Clin Cancer Res"},{"key":"1942_CR45","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.tcb.2016.06.005","volume":"26","author":"J Chu","year":"2016","unstructured":"Chu J, Cargnello M, Topisirovic I, Pelletier J. Translation initiation factors: reprogramming protein synthesis in cancer. Trends Cell Biol. 2016;26:918\u201333.","journal-title":"Trends Cell Biol"},{"key":"1942_CR46","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/s41388-023-02636-3","volume":"42","author":"X He","year":"2023","unstructured":"He X, Zhou Y, Chen W, Zhao X, Duan L, Zhou H, et al. Repurposed pizotifen malate targeting NRF2 exhibits anti-tumor activity through inducing ferroptosis in esophageal squamous cell carcinoma. Oncogene. 2023;42:1209\u201323.","journal-title":"Oncogene"},{"key":"1942_CR47","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1021\/acschembio.6b00651","volume":"11","author":"A Singh","year":"2016","unstructured":"Singh A, Venkannagari S, Oh KH, Zhang YQ, Rohde JM, Liu L, et al. Small molecule inhibitor of NRF2 nelectively intervenes therapeutic resistance in KEAP1-deficient NSCLC tumors. ACS Chem Biol. 2016;11:3214\u201325.","journal-title":"ACS Chem Biol"},{"key":"1942_CR48","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","volume":"98","author":"M Yamamoto","year":"2018","unstructured":"Yamamoto M, Kensler TW, Motohashi H. The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiol Rev. 2018;98:1169\u2013203.","journal-title":"Physiol Rev"},{"key":"1942_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105575","volume":"167","author":"S Mirzaei","year":"2021","unstructured":"Mirzaei S, Mohammadi AT, Gholami MH, Hashemi F, Zarrabi A, Zabolian A, et al. Nrf2 signaling pathway in cisplatin chemotherapy: potential involvement in organ protection and chemoresistance. Pharmacol Res. 2021;167:105575.","journal-title":"Pharmacol Res"},{"key":"1942_CR50","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1093\/abbs\/gmz069","volume":"51","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Xiong R, Li C, Xu M, Guo M. LncRNA TUG1 promotes cisplatin resistance in esophageal squamous cell carcinoma cells by regulating Nrf2. Acta Biochim Biophys Sin. 2019;51:826\u201333.","journal-title":"Acta Biochim Biophys Sin"},{"key":"1942_CR51","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3892\/mmr.2020.10909","volume":"21","author":"D Shen","year":"2020","unstructured":"Shen D, Wang Y, Niu H, Liu C. Gambogenic acid exerts anticancer effects in cisplatin\u2011resistant non\u2011small cell lung cancer cells. Mol Med Rep. 2020;21:1267\u201375.","journal-title":"Mol Med Rep"},{"key":"1942_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0314-6","volume":"9","author":"L Xu","year":"2018","unstructured":"Xu L, Meng X, Xu N, Fu W, Tan H, Zhang L, et al. Gambogenic acid inhibits fibroblast growth factor receptor signaling pathway in erlotinib-resistant non-small-cell lung cancer and suppresses patient-derived xenograft growth. Cell Death Dis. 2018;9:262.","journal-title":"Cell Death Dis"},{"key":"1942_CR53","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.bbrc.2018.12.028","volume":"508","author":"Q Xu","year":"2019","unstructured":"Xu Q, Guo J, Chen W. Gambogenic acid reverses P-glycoprotein mediated multidrug resistance in HepG2\/Adr cells and its underlying mechanism. Biochem Biophys Res Commun. 2019;508:882\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"1942_CR54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","volume":"34","author":"M Rojo de la Vega","year":"2018","unstructured":"Rojo de la Vega M, Chapman E, Zhang DD. NRF2 and the hallmarks of cancer. Cancer Cell. 2018;34:21\u201343.","journal-title":"Cancer Cell"},{"key":"1942_CR55","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/ptr.7614","volume":"37","author":"J Wu","year":"2023","unstructured":"Wu J, Wang D, Zhou J, Li J, Xie R, Li Y, et al. Gambogenic acid induces apoptosis and autophagy through ROS-mediated endoplasmic reticulum stress via JNK pathway in prostate cancer cells. Phytother Res. 2023;37:310\u201328.","journal-title":"Phytother Res"},{"key":"1942_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110602","volume":"382","author":"Z Liu","year":"2023","unstructured":"Liu Z, Wang X, Li J, Yang X, Huang J, Ji C, et al. Gambogenic acid induces cell death in human osteosarcoma through altering iron metabolism, disturbing the redox balance, and activating the P53 signaling pathway. Chem Biol Interact. 2023;382:110602.","journal-title":"Chem Biol Interact"},{"key":"1942_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153306","volume":"78","author":"Q Zhao","year":"2020","unstructured":"Zhao Q, Zhong J, Bi Y, Liu Y, Liu Y, Guo J, et al. Gambogenic acid induces Noxa-mediated apoptosis in colorectal cancer through ROS-dependent activation of IRE1\u03b1\/JNK. Phytomedicine. 2020;78:153306.","journal-title":"Phytomedicine"},{"key":"1942_CR58","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41568-021-00380-y","volume":"21","author":"L Fabbri","year":"2021","unstructured":"Fabbri L, Chakraborty A, Robert C, Vagner S. The plasticity of mRNA translation during cancer progression and therapy resistance. Nat Rev Cancer. 2021;21:558\u201377.","journal-title":"Nat Rev Cancer"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01942-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01942-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01942-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:03:39Z","timestamp":1790820219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01942-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":58,"alternative-id":["1942"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01942-2","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"28 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}